After care of prostatic cancer
Ebert, T.
Der Urologe. Ausg. a 31(4): 196-197
1992
ISSN/ISBN: 0340-2592 PMID: 1381125 Document Number: 393977
Document emailed within 1 workday
Related Documents
Hao, X.K. 1993: Radioimmunodetection of prostatic cancer: in vivo 131I-gamma-seminoprotein for diagnosis of prostatic cancer by nuclear imaging Zhonghua Yi Xue Za Zhi 73(11): 655-657; 700Oishi, K.; Arai, Y.; Takeuchi, H.; Yoshida, O. 1993: Side effects of estrogen administration to prostatic cancer patients: clinical and statistical survey of 109 prostatic cancer cases of Kyoto University Hospital Hinyokika Kiyo. Acta Urologica Japonica 39(1): 23-28
Gu, F. 2000: Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China Chinese Medical Journal 113(4): 299-302
Paul, B.D.; Serrano, J.A.; Friedman, A.E.; Sarlos, I.J.; Sternberger, N.J.; Wasserkrug, H.L.; Seligman, A.M. 1977: New agents for prostatic cancer activated specifically by prostatic acid phosphatase Cancer Treatment Reports 61(2): 259-263
Rodríguez Rodríguez, R.; Mayayo Dehesa, T.; Galbis Sanjuan, F.; Burgos Revilla, F.J.; Jiménez Cidre, M.; García González, R. 1996: Chronic prostatic inflammation: a confounding factor in the diagnosis of prostatic cancer Archivos Espanoles de Urologia 49(7): 669-673
Goldenberg, D.M.; DeLand, F.H. 1984: Clinical studies of prostatic cancer imaging with radiolabeled antibodies against prostatic acid phosphatase Urologic Clinics of North America 11(2): 277-281
Teni, T.R.; Bandivdekar, A.H.; Sheth, A.R.; Sheth, N.A. 1989: Prostatic inhibin-like peptide quantified in urine of prostatic cancer patients by enzyme-linked immunosorbent assay Clinical Chemistry 35(7): 1376-1379
Abdalla, A.M.; Oliver, J.A. 1971: SV40 virus transformed prostatic carcinoma in the hamster. I. Comparisons of lactate dehydrogenase isoenzymes with human prostatic cancer Investigative Urology 8(4): 442-447
Lowe, F.C.; Isaacs, J.T. 1984: Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model Cancer Research 44(2): 744-752
Herranz Amo, F.; Díez Cordero, J.M.; Verdú Tartajo, F.; Lledó García, E.; Subirá Castillón, C.; González Chamorro, F.; Rodríguez Fernández, E. 1997: Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer Archivos Espanoles de Urologia 50(3): 253-258
Benvenuti, M.; Legnaioli, M.; Melone, F.; Taddei, I.; Tarquini, B. 1983: Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa) Chronobiologia 10(4): 383-386
Schubert, J.; Gorski, J. 1983: Zum biologischen Verhalten des Prostatakarzinoms. II: Klinisch-operative Studien zur lymphogenen Metastasierung des Prostatakarzinoms - Le comportement biologique du cancer prostatique. II: Etudes clinicochirurgicales sur les métastases lymphogènes du cancer prostatique - Biological behaviour of prostatic carcinoma. II. Clinical operative studies of lymphatic metastasizing of prostatic carcinoma der Urologe. Ausgabe a 22: 356-359
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Machida, T.; Ikemoto, I. 1987: Hormone therapy of male genital cancer (prostatic cancer) Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(10): 2845-2852
Fujita, K. 1986: Progress in cancer therapy. 12. Prostatic cancer Nursing Technique 32(16): 2084-2087
Clavé, M. 1976: Postoperative care for prostatic adenomas Revue de l'Infirmiere 26(8): 671-677
Soulié, M.; Barré, C.; Beuzeboc, P.; Chautard, D.; Cornud, F.ço.; Eschwege, P.; Fontaine, E.; Molinié, V.; Moreau, J.-L.; Péneau, M.; Ravery, V.; Rébillard, X.; Richaud, P.; Ruffion, A.; Salomon, L.; Staerman, F.; Villers, A. 2004: Prostatic cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 14(4 Suppl 1: 913; 915-955
Soulié, M. 2003: Epidemiology of prostatic cancer Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 13(5 Suppl 2: 1261
Hohbach, C.; Dhom, G. 1980: Pathology of prostatic cancer Scandinavian Journal of Urology and Nephrology. Supplementum 55: 37-47
Laufer, M.; Matzkin, H.; Braf, Z.F. 1995: Screening for prostatic cancer Harefuah 129(1-2): 39-43